Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin

Phytomedicine

Volumn 18, Issue 5, 2011, Pages 380-383

  Messier, Céline ^a   Epifano, Francesco ^b   Genovese, Salvatore ^b   Grenier, Daniel ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

4 Hydroxycordoin; Biofilm; Candida albicans; Stomatitis; Yeast hyphal transition

Indexed keywords

4 HYDROXYCORDOIN; ANTIFUNGAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS GROWTH; FUNGUS HYPHAE; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CHALCONES; HUMANS; HYPHAE; MICROBIAL SENSITIVITY TESTS; VIRULENCE;

CANDIDA ALBICANS;

EID: 79952738952     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2011.01.013     Document Type: Article

References (26)

1. Avila, H.P., Smania, E.F.A., Delle Monache, F., Smania, A., 2008. Structure-activity relationship of antibacterial chalcones. Bioorg. Med. Chem. Lett. 16, 9790-9794.
2. Batovska, D., Parushev, S.T., Slavova, A., Bankova, V., Tsvetkova, I., Ninova, M., Najdenski, H., 2007. Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans. Eur. J. Med. Chem. 42, 87-92.
3. Braga, P.C., Alfieri, M., Culini, M., Dal Sasso, M., 2007. Inhibitory activity of thymol against the formation and viability of Candida albicans hyphae. Mycoses 50, 502-506.
4. Budtz-Jorgensen, E., Bertram, U., 1970. Denture stomatitis. 1. The etiology in relation to trauma and infection. Acta Odontol. Scand. 28, 283.
5. Cao, Y.Y., Dai, B.D., Wang, Y., Huang, S., Xu, Y.G., 2008. In vitro activity of baicalein against Candida albicans biofilms. Int. J. Antimicrob. Agents 32, 73-77.
6. Dalleau, S., Cateau, E., Bergès, T., Berjeaud, J.M., Imbert, C., 2008. In vitro activity of terpenes against Candida biofilms. Int. J. Antimicrob. Agents 31, 572-576.
7. Donlan, R.M., Costerton, J.W., 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167-193.
8. Epifano, F., Genovese, S., Menghini, L., Curini, M., 2007. Chemistry and pharmacology of oxyprenylated secondary plant metabolites. Phytochemistry 68, 939-953. (Pubitemid 46413340)
9. Evans, E.G., Odds, F.C., Richardson, M.D., Holland, K.T., 1974. The effect of growth medium of filament production in Candida albicans. Sabouraudia 12, 112-119.
10. Evensen, N.A., Braun, P.C., 2009. The effects of tea polyphenols on Candida albicans: inhibition of biofilm formation and proteasome inactivation. Can. J. Microbiol. 55, 1033-1039.
11. Genovese, S., Epifano, F., Curini, M., Dudra-Jastrzebska, M., Luszczki, J.J., 2009. Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents. Bioorg. Med. Chem. Lett. 19, 5419-5422.
12. Ha, K.C., White, T.C., 1999. Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans. Antimicrob. Agents Chemother. 43, 763-768.
13. Han, Y., 2007. Synergy anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism. Biol. Pharm. Bull. 30, 1693-1696.
14. Hawser, S.P., Douglas, L.J., 1995. Resistance of Candida albicans biofilms to antifungal agents in-vitro. Antimicrob. Agents Chemother. 39, 2128-2131.
15. Hellstein, J., Vawter-Hugart, H., Fotos, P., Schmid, J., Soll, D.R., 1993. Genetic similarity and phenotypic diversity of commensal and pathogenic strains of Candida albicans isolated from the oral cavity. J. Clin. Microbiol. 31, 3190-3199.
16. Jackson, B.E., Wilhelmus, K.R., Mitchell, B.M., 2007. Genetically regulated filamentation contributes to Candida albicans virulence during corneal infection. Microb. Pathol. 42, 88-93.
17. Jones, S., White, G., Hunter, P.R., 1994. Increased phenotypic switching in strains of Candida albicans associated with invasive infections. J. Clin. Microbiol. 32, 2869-2870.
18. Lacasse, M., Fortier, C., Trudel, L., Collet, A.J., Deslauriers, N., 1990. Experimental oral candidosis in the mouse: microbiological and histological aspects. J. Oral Pathol. Med. 19, 136-141.
19. Lopez-Martinez, R., 2010. Candidosis, a new challenge. Clin. Dermatol. 28, 178-184.
20. Samaranayake, L.P., Keung Leung, W.K., Jin, L., 2009. Oral mucosal fungal infections. Periodontol. 2000 49, 39-59.
21. Sato, M., Tsuchiya, H., Akagiri, M., Takagi, N., Iinuma, M., 1997. Growth inhibition of oral bacteria related to denture stomatitis by anti-candidal chalcones. Aust. Dent. J. 42, 343-346.
22. Seneviratne, C.J., Jin, L., Samaranayake, L.P., 2008. Biofilm lifestyle of Candida: a mini review. Oral Dis. 14, 582-590.
23. Soll, D.R., 2002. Phenotypic switching. In: Calderone, R. (Ed.), Candida and Candidiasis. ASM Press, Washington, pp. 123-142.
24. Soll, D.R., Langtimm, C.J., McDowell, J., Hicks, J., Galask, R., 1987. High-frequency switching in Candida strains isolated from vaginitis patients. J. Clin. Microbiol. 25, 1611-1622.
25. Taweechaipapong, S., Choopan, T., Singhara, S., Chatrchaiwiwatana, S., Wongkham, S., 2005. In vitro effect of Streblus asper leaf-extract on adhesion of Candida albicans to human buccal epithelial cells. J. Ethnopharmacol. 96, 221-226.
26. Tsuchiya, H., Sato, M., Akagiri, M., Takagi, N., Tanaka, T., Linuma, M., 1994. Anti-Candida activity of synthetic hydroxychalcones. Pharmazie 49, 756-758. (Pubitemid 24320054)